Vioxx

Law360, New York (February 15, 2012, 7:14 PM ET) -- A Kentucky appeals court on Friday overturned the certification of a statewide class of Vioxx users in an action accusing Merck & Co. Inc. of concealing the dangerous cardiac side effects of the recalled painkiller.  

By Cathy O’Neil, a data scientist who lives in New York City and writes at mathbabe.org Yesterday I caught a lecture at Columbia given by statistics professor David Madigan, who explained to us the story of Vioxx and Merck. It’s fascinating and I was lucky to get permission to retell it here. Disclosure Madigan has been a paid consultant to work on litigation against Merck. He doesn’t consider Merck to be an evil company by any means, and...  

Diane P. Sullivan, the Princeton, N.J.-based litigator who secured a 2005 victory for client Merck in the Vioxx products liability lawsuit, has left Dechert for New York mega-firm Weil Gotshal & Manges. Joining Sullivan in the move is partner Kathleen O’Connor, the former in-house Merck lawyer who ultimately joined Dechert and worked on the Vioxx case. Sullivan, who joined Dechert in 2001 from Lowenstein Sandler, specializes in litigating...  

Drugmaker Merck & Co. said Thursday that it has reached a deal to settle all lawsuits in Canada over its recalled painkiller Vioxx, for up to 36.9 million Canadian dollars ($36.5 million). Merck and attorneys representing hundreds of Vioxx users in Canada said the final payment will be at least $21.6 million and could go as high as $36.5 million. Merck and representatives of the plaintiffs have signed...  

VIOXX DEAL: Merck and lawyers for Canadian Vioxx users have struck a deal, awaiting approval by courts in provinces there, to end lawsuits filed by hundreds of people claiming harm from the drugmaker's recalled painkiller Vioxx.  

Pharmaceutical giant Merck said Thursday it has agreed to pay up to CAN$36.8 million (US$36.3 million) to resolve all suits brought against it in Canada over its former hit painkiller Vioxx.Merck voluntarily withdrew the popular medicine, known by its generic name Rofecoxib, from the market in 2004 after interim clinical trials linked the anti-inflammatory drug to a higher risk of heart attacks and stroke.Since then Merck has faced numerous...  

via ottawacitizen.com The amount for Vioxx users in Canada will be between $11.3 million and $26.4 million, with the amount determined by the final number of eligible claimants. All amounts are in Canadian dollars. "Claims for myocardial infarction and sudden cardiac death will be evaluated on an individual basis by an independent administrator based on objective criteria related to various factors, including duration of Vioxx use, age...  

MRK-N has reached a deal to settle all lawsuits in Canada over its recalled painkiller Vioxx. Merck and attorneys representing hundreds of Vioxx users in Canada say the final payment will be at ...  

TRENTON, N.J. (AP) - Drugmaker Merck & Co. said that it has reached a deal to settle all lawsuits in Canada over its recalled painkiller Vioxx, for up to 36.9 million Canadian dollars ($36.5 million). Merck and attorneys representing hundreds of ...  

Drugmaker Merck & Co. said Thursday that it has reached a deal to settle all lawsuits in Canada over its recalled painkiller Vioxx, for up to about $37 million. Merck and attorneys representing thousands of Vioxx users in Canada say the final payment will ...  

(AP) WHITEHOUSE STATION, N.J. — Drugmaker Merck & Co. has reached a deal to settle all lawsuits in Canada over its recalled painkiller Vioxx, for up to 36.9 million Canadian dollars ($36.5 million). Merck and attorneys representing hundreds of ...  

A pharmaceutical titan has agreed to compensate more than 1,000 Canadians who blame the company’s pain medication for increasing their risk of cardiac complications.  

TRENTON, N.J. (AP) — Drugmaker Merck & Co. said Thursday that it has reached a deal to settle all lawsuits in Canada over its recalled painkiller Vioxx, for up to 36.9 million Canadian dollars ($36.5 million). Merck and attorneys representing ...  

Pharmaceutical giant Merck Frosst has settled a class-action lawsuit by Canadians who used its controversial heart drug Vioxx. “We’re very happy,” said Regina lawyer Tony Merchant, whose firm represented about 1,000 clients.  

WHITEHOUSE STATION, N.J., Jan. 19, 2012, 2012 (Canada NewsWire via COMTEX) -- Merck (NYSE:MRK) , known as MSD outside the United States and Canada, announced today that it has entered into an agreement to resolve all claims related to Vioxx® in Canada.  

MONTREAL: Pharmaceutical giant Merck said Thursday it has agreed to pay up to CAN$36.8 million (US$36.3 million) to resolve all suits brought against it in Canada over its former hit painkiller Vioxx.  

Merck touted the drug as a treatment for rheumatoid arthritis starting in 1999 despite the fact the U.S. government had not approved its use for that purpose. While doctors were permitted to write prescriptions for the drug, Merck was forbidden from ...  

A pharmaceutical titan has agreed to compensate more than a thousand Canadians who blame the company’s pain medication for increasing their risk of cardiac complications. New Jersey-based Merck and Co. Inc., which maintains no wrongdoing, announced ...  

A pharmaceutical titan has agreed to compensate more than a thousand Canadians who blame the company's pain medication for increasing their risk of cardiac complications. New Jersey-based Merck and Co. Inc., which maintains no wrongdoing, announced ...  

LONDON, ON, A settlement has been reached which, if approved by the courts and fully implemented, will resolve Vioxx claims across Canada. Class actions were filed across Canada on behalf of individuals who used and/or purchased Vioxx, a prescription pain ...  

It will also plead guilty to a misdemeanor charge that it marketed Vioxx as a treatment for rheumatoid arthritis before getting U.S. Food and Drug Administration approval. Merck stopped selling Vioxx in 2004 after evidence showed the drug ...  

Drug maker denies liability but will pay out up to $36.5-million  

A Canadian class-action lawsuit against Merck, the company that made the arthritis drug Vioxx, has been settled for an award of $37-million  

Vioxx was introduced into the market in 1999 but was not approved by the FDA as an indication for rheumatoid arthritis until 2002.  While it is not illegal for a physician to prescribe a drug for an unapproved use, federal law prohibits a manufacturer ...